Comparison of quetiapine, olanzapine, and risperidone in schizophrenia

被引：4
|
作者：
Sacchetti, E
Valsecchi, P
Regini, C
Galluzzo, A
Cacciani, P
Agrimi, E
Mencacci, C
机构：
[1] Univ Brescia, Sch Med, Chair Psychiat, I-25121 Brescia, Italy
[2] Univ Brescia, Spedali Civili, Psychiat Unit, I-25121 Brescia, Italy
[3] Brescia Spedali Civili, Dept Mental Hlth, Brescia, Italy
[4] Azienda Osped, Ist Ospitalieri Cremona, Dept Mental Hlth, Cremona, Italy
[5] Osped Fatebenefratelli & Oftalm Milan, Dept Mental Hlth, Milan, Italy
来源：
EUROPEAN NEUROPSYCHOPHARMACOLOGY | 2004年 / 14卷
关键词：
D O I：
10.1016/S0924-977X(04)80342-0
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S286 / S286
页数：1
相关论文
共 50 条
  • [21] Weight gain in patients with schizophrenia treated with risperidone, olanzapine, quetiapine or haloperidol:: results of the EIRE study
    Bobes, J
    Rejas, J
    Garcia-Garcia, M
    Rico-Villademoros, F
    García-Portilla, MP
    Fernández, I
    Hernández, G
    SCHIZOPHRENIA RESEARCH, 2003, 62 (1-2) : 77 - 88
  • [22] Diabetes risk associated with use of olanzapine, quetiapine, and risperidone in Veterans Health Administration patients with schizophrenia
    Lambert, Bruce L.
    Cunningham, Francesca E.
    Miller, Donald R.
    Dalack, Gregory W.
    Hur, Kwan
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 2006, 164 (07) : 672 - 681
  • [23] Weight gain in Korean schizophrenia inpatients: A comparison of risperidone and olanzapine
    Kim, H
    Lee, KJ
    Lee, SH
    Chung, YC
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2004, 14 : S255 - S255
  • [24] Haloperidol, olanzapine and risperidone reduce treatment failure compared to aripiprazole, quetiapine and ziprasidone in acute schizophrenia
    Taylor, David
    EVIDENCE-BASED MENTAL HEALTH, 2007, 10 (03) : 76 - 76
  • [25] Effectiveness of olanzapine, quetiapine, and risperidone in patients with chronic schizophrenia after discontinuing perphenazine: A CATIE study
    Stroup, T. Scott
    Lieberman, Jeffrey A.
    McEvoy, Joseph P.
    Swartz, Marvin S.
    Davis, Sonia M.
    Capuano, George A.
    Rosenheck, Robert A.
    Keefe, Richard S. E.
    Miller, Alexander L.
    Belz, Irving
    Hsiao, John K.
    AMERICAN JOURNAL OF PSYCHIATRY, 2007, 164 (03): : 415 - 427
  • [26] Glucose metabolism and insulin sensitivity: Differential changes in patients with schizophrenia taking quetiapine, olanzapine or risperidone
    Ratner, Robert E.
    Newcomer, John W.
    Eriksson, Jan W.
    Emsley, Robin
    Meulien, Didier
    Miller, Frank
    Leonova-Edlund, Julia
    Leong, Ronald
    Brecher, Martin
    DIABETES, 2007, 56 : A164 - A165
  • [27] Pharmacy cost evaluation of risperidone, olanzapine, and quetiapine for the treatment of schizophrenia in acute care inpatient settings
    Mladsi, DM
    Grogg, AL
    Irish, WD
    Lopez, RB
    Degen, K
    Swann, A
    Nimsch, CT
    CURRENT MEDICAL RESEARCH AND OPINION, 2004, 20 (12) : 1883 - 1893
  • [28] Differential effects of quetiapine, olanzapine and risperidone on glucose metabolism: A 24-week study in schizophrenia
    Brecher, M.
    Newcomer, J. W.
    Ratner, R. E.
    Eriksson, J. W.
    Emsley, R.
    Meulien, D.
    Miller, F.
    Risberg, S.
    Leonova-Edlund, J.
    Leong, R.
    SCHIZOPHRENIA BULLETIN, 2007, 33 (02) : 423 - 423
  • [29] Olanzapine and quetiapine: higher diabetes risk than risperidone
    Reactions Weekly, 2006, 1106 (1) : 5 - 5
  • [30] Comparison of risperidone, olanzapine and quetiapine for body weight, serum blood glucose and prolactin levels
    Chaudhry, H.
    Arshad, N.
    Niaz, S.
    Suleman, T.
    Mufti, K.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2009, 19 : S511 - S512
12345